PUMA BIOTECHNOLOGY, INC. PBYI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-03-21
PUMA BIOTECHNOLOGY, INC. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,942,413 | $12.4M |
| BlackRock Finance, Inc. | 3,572,806 | $11.6M |
| MILLENNIUM MANAGEMENT LLC | 1,477,519 | $9.4M |
| AQR CAPITAL MANAGEMENT LLC | 800,194 | $5.1M |
| D. E. Shaw & Co., Inc. | 351,235 | $2.2M |
| CITADEL ADVISORS LLC | 29,959 | $191,438 |
| TWO SIGMA INVESTMENTS, LP | 13,000 | $83,070 |
Source: SEC EDGAR filings · CIK 0001401667 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.